MUSK and myasthenia gravis: These encouraging preclinical results prompted the launch of clinical trials, including the Descartes‐08 CAR‐T cell trial (NCT04146051), aimed at assessing the safety and effectiveness of MuSK‐targeted CAR‐T cells in patients with generalized MG.